Org 5592696651Linnégatan 10 DResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20200 employees
Revenue 2024
SEK 1,2M
+52% vs 2023
EBITDA margin
26.2%
-36% vs 2023
Equity ratio
43.0%
Financial strength
Net profit 2024
SEK 197K
-36% vs 2023
EBITDA — year on yearSEK millionsKey figuresAnnual report 2024
Revenue
SEK 1,2M
+52%
EBITDA
SEK 326K
-36%
Net profit
SEK 197K
-36%
Total assets
SEK 1,2M
+35%
Equity
SEK 526K
+60%
Employees
0
—
Company information
Legal name
Brave Bioscience AB
Org number
5592696651
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
2 september 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva verksamhet inom forskning, utveckling, rådgivning, undervisning och förtroendeuppdrag inom det medicinska området och därmed förenlig verksamhet.
Contact
Address
Linnégatan 10 D
Email
legal@bravebio.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.